Press Release of Thursday, 28.04.2016

"ERC Advanced Grant“ für Didier Stainier

EU fördert Max-Planck-Institut für Herz- und Lungenforschung mit 2,5 Millionen Euro – Suche nach...

Press Release of Wednesday, 17.02.2016

Ethisches Handeln greifbar gemacht

Singberg-Schüler informieren sich am Max-Planck-Institut über praktische Fragen von Ethik und Moral



Service Group Mass Spectrometry
Biomolecular Mass Spectrometry Scientific Service Group Leader (m/f)

Reference number: 09/2016

Dept. II: Pharmacology
Research Scientist/ Post-Doc in Cardiovascular Pharmacology

To study pharmacology and pathophysiology of G-protein-coupled receptors.



Tuesday, 31.05.2016, 11:00 h

Pharmacological Approaches to Promote Endogenous Heart Regeneration and Rejuvenation

Patrick C.H. Hsieh, MD, PhD, FAHA


Research Departments

Cardiac Development and Remodelling

Focus is exploring the molecular basics of heart development and cardiac diseases and to investigate cardiac regeneration and repair processes.


The department investigates basic molecular mechanisms of cellular signaling pathways. Clinical projects deal with mechanisms of pathophysio-logical processes and drug actions.

Developmental Genetics

The department is interested in the formation, function and regeneration of several vertebrate organs including the cardiovascular system(zebrafish) and lungs (mouse).

Lung Development and Remodelling

The department has a translational research back- ground and investigates genesis of lung diseases as well as lung development and regeneration.

Scientific Service Groups

Mass Spectrometry - N.N.

MRI - Dr. Astrid Wietelmann

Bioinformatics - Dr. Mario Looso

Morphometry- PD Dr. Sawa Kostin

Animal Facility - Dr. Nouha Ritschel

Transgenic Service

© 2016 Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany